CircRNAs derived from the tyrosine phosphatase PTPN22 impact chemosensitivity in ALK-positive T-cell lymphomas
Abstract
Anaplastic large cell lymphoma (ALCL) is a subtype of T-cell non-Hodgkin lymphoma (NHL), classified into ALK(+) and ALK(–) subtypes, based on translocations of the ALK gene. ALK(+) ALCL have a favorable prognosis with polychemotherapy, yet some patients develop early chemoresistance, leading to treatment failure. The molecular mechanisms underlying this resistance remain poorly defined. Circular RNAs (circRNAs) have recently emerged as regulators of drug resistance in cancer, but their role in T-NHLs is largely unexplored. A comprehensive analysis of circRNA expression was performed here in primary ALK(+) ALCL biopsies. RNA-Seq identified 12 circRNAs associated with early relapse, including isoforms from the PTPN22 gene (circPTPN22), significantly upregulated in relapsed patients. Functional analyses showed that the ALK/STAT3 signaling pathway regulates circPTPN22 expression, linking oncogenic signaling to circRNA regulation. It was also found that circPTPN22 isoforms modulate responses to chemotherapy by regulating the arginine methyltransferase CARM1, a key enzyme involved in transcriptional regulation. Loss of CARM1 expression promoted drug tolerance in chemosensitive ALK(+) lymphoma cells. These findings identify the circPTPN22/CARM1 axis as a regulator of chemosensitivity and propose CARM1 inhibition as a potential strategy to overcome chemoresistance in patients with ALK(+) ALCL.
Related
- Identification and bioinformatic functional annotation of circRNAs mediating phenotypic differences in hair follicle cycling of Jinlan cashmere goats
- One-carbon metabolism controls colorectal cancer cell state and chemosensitivity through chromatin remodeling
- Unraveling circRNAs and ceRNA regulatory networks underlying sex-specific gametogenesis impairment in triploid Pacific oysters (Crassostrea gigas).
- MASTL Kinase Mediates the DNA Replication Stress Response Through PP2A/B55 Phosphatase Modulation
- Kinase-phosphatase cycles drive self-sustained oscillations of protein condensates
BibTeX
@article{andraos2026circrnas,
title = {{CircRNAs derived from the tyrosine phosphatase PTPN22 impact chemosensitivity in ALK-positive T-cell lymphomas}},
author = {Elissa Andraos and Steffen Fuchs and Chloé Bessière and Lola Colras and Sandra Dailhau and Marina Bousquet and Aurore Touzart and Ludovic Lhermitte and Christine Gaspin and Stéphane Pyronnet and Laurence Lamant and Fabienne Meggetto and Loelia Babin},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-54978-z},
url = {https://hal.inrae.fr/hal-05697827v2},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - CircRNAs derived from the tyrosine phosphatase PTPN22 impact chemosensitivity in ALK-positive T-cell lymphomas
AU - Elissa Andraos
AU - Steffen Fuchs
AU - Chloé Bessière
AU - Lola Colras
AU - Sandra Dailhau
AU - Marina Bousquet
AU - Aurore Touzart
AU - Ludovic Lhermitte
AU - Christine Gaspin
AU - Stéphane Pyronnet
AU - Laurence Lamant
AU - Fabienne Meggetto
AU - Loelia Babin
PY - 2026
DA - 2026/10/14
JO - Scientific Reports
DO - 10.1038/s41598-026-54978-z
UR - https://hal.inrae.fr/hal-05697827v2
AB - Anaplastic large cell lymphoma (ALCL) is a subtype of T-cell non-Hodgkin lymphoma (NHL), classified into ALK(+) and ALK(–) subtypes, based on translocations of the ALK gene. ALK(+) ALCL have a favorable prognosis with polychemotherapy, yet some patients develop early chemoresistance, leading to treatment failure. The molecular mechanisms underlying this resistance remain poorly defined. Circular RNAs (circRNAs) have recently emerged as regulators of drug resistance in cancer, but their role in T-NHLs is largely unexplored. A comprehensive analysis of circRNA expression was performed here in primary ALK(+) ALCL biopsies. RNA-Seq identified 12 circRNAs associated with early relapse, including isoforms from the PTPN22 gene (circPTPN22), significantly upregulated in relapsed patients. Functional analyses showed that the ALK/STAT3 signaling pathway regulates circPTPN22 expression, linking oncogenic signaling to circRNA regulation. It was also found that circPTPN22 isoforms modulate responses to chemotherapy by regulating the arginine methyltransferase CARM1, a key enzyme involved in transcriptional regulation. Loss of CARM1 expression promoted drug tolerance in chemosensitive ALK(+) lymphoma cells. These findings identify the circPTPN22/CARM1 axis as a regulator of chemosensitivity and propose CARM1 inhibition as a potential strategy to overcome chemoresistance in patients with ALK(+) ALCL.
SN - 2045-2322
ER -